Rigel Pharmaceuticals Inc. | Key People and Executives
Gregg Anthony Lapointe
Independent Director
Brian L. Kotzin
Independent Director
Keith A. Katkin
Independent Director
Peter S. Ringrose
Independent Director
Bradford S. Goodwin
Independent Director
Walter H. Moos
Independent Director
Raul R. Rodriguez
President & Chief Executive Officer
Dean L. Schorno
Chief Financial Officer & Executive Vice President
Anne-Marie S. Duliege
Chief Medical Officer & Executive Vice President
Giovanna Matthews
Executive Director-Market Access
Esteban S. Masuda
Senior Vice President-Research
Joseph Lasaga
VP-Business Development & Alliance Management
Eldon C. Mayer
Chief Commercial Officer & Executive VP
Nelson Cabatuan
Principal Accounting Officer, VP & Controller
Stacy Markel
Executive Vice President-Human Resources
Dolly A. Vance
Secretary, EVP-Corporate Affairs & General Counsel
Gregg Anthony Lapointe
Independent Director
Brian L. Kotzin
Independent Director
Keith A. Katkin
Independent Director
Peter S. Ringrose
Independent Director
Bradford S. Goodwin
Independent Director
Walter H. Moos
Independent Director
| Address |
1180 Veterans Boulevard
South San Francisco California 94080
United States
|
|
Employees
|
- |
| Website |
http://www.rigel.com |
| Updated |
07/08/2019 |
| Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. It focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. |
